Lapaquistat Uses, Dosage, Side Effects and more
Lapaquistat is under investigation in clinical trial NCT00256178 (Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.).
| Trade Name | Lapaquistat |
| Generic | Lapaquistat |
| Lapaquistat Other Names | Lapaquistat |
| Type | |
| Formula | C31H39ClN2O8 |
| Weight | Average: 603.11 Monoisotopic: 602.2394939 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
